Search

Your search keyword '"Sulfadiazine pharmacology"' showing total 518 results

Search Constraints

Start Over You searched for: Descriptor "Sulfadiazine pharmacology" Remove constraint Descriptor: "Sulfadiazine pharmacology"
518 results on '"Sulfadiazine pharmacology"'

Search Results

1. Biofilm enhanced the mitigations of antibiotics and resistome in sulfadiazine and trimethoprim co-contaminated soils.

2. Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis.

3. Sulfadiazine proliferated antibiotic resistance genes in the phycosphere of Chlorella pyrenoidosa: Insights from bacterial communities and microalgal metabolites.

4. Efficient peroxymonosulfate activation by nanoscale zerovalent iron for removal of sulfadiazine and sulfadiazine resistance bacteria: Sulfidated modification or not.

5. Effects of environmentally relevant concentrations of oxytetracycline and sulfadiazine on the bacterial communities, antibiotic resistance genes, and functional genes are different between maize rhizosphere and bulk soil.

6. Inhibitor of P-glycoprotein-mediated drug transport by curcumin in broiler chickens.

7. Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo.

8. The healing effect of a mixture of Arnebia euchroma and animal fat on burn wounds in rats in comparison with sulfadiazine.

9. Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles.

10. Visible light-driven photocatalysts, quantum chemical calculations, ADMET-SAR parameters, and DNA binding studies of nickel complex of sulfadiazine.

11. Understanding the cometabolic degradation of sulfadiazine by an enriched ammonia oxidizing bacteria culture from both extracellular and intracellular perspectives.

12. Resistance profiles of microbial communities in maize rhizospheres to the introduction of exogenous antibiotics to agricultural systems with a high arsenic geological background.

13. Effects of successional sulfadiazine exposure on biofilm in moving bed biofilm reactor: Secretion of extracellular polymeric substances, community activity and functional gene expression.

14. In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.

15. Red osier dogwood extract vs. trimethoprim-sulfadiazine (Part 2). Pharmacodynamic effects on ileal and cecal microbiota of broiler chickens challenged orally with Salmonella Enteritidis.

16. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.

17. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.

18. Antibiotic sulfadiazine degradation by persulfate oxidation: Intermediates dependence of ecotoxicity and the induction of antibiotic resistance genes.

19. Presence and Depletion of Sulfadiazine, Trimethoprim, and Oxytetracycline into Feathers of Treated Broiler Chickens and Impact on Antibiotic-Resistant Bacteria.

20. Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.

21. Dextran Fluorescent Probes Containing Sulfadiazine and Rhodamine B Groups.

22. The antibacterials ciprofloxacin, trimethoprim and sulfadiazine modulate gene expression, biomarkers and metabolites associated with stress and growth in gilthead sea bream (Sparus aurata).

23. Standard Selection Treatments with Sulfadiazine Limit Plasmodium yoelii Host-to-Vector Transmission.

24. Inhibition of Toxoplasma gondii Growth by Dihydroquinine and Its Mechanisms of Action.

25. Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.

26. Effect of pig manure-derived sulfadiazine on species distribution and bioactivities of soil ammonia-oxidizing microorganisms after fertilization.

27. Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis.

28. A pH-sensitive oxidized-dextran based double drug-loaded hydrogel with high antibacterial properties.

29. Affordable automated phenotypic antibiotic susceptibility testing method based on a contactless conductometric sensor.

30. Co-delivery of superfine nano-silver and solubilized sulfadiazine for enhanced antibacterial functions.

31. Sulfadiazine Masquerading as a Natural Product from Scilla madeirensis (Scilloideae).

32. Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies.

33. Some Studies in Sulfadiazine Incorporating Pyridine, Pyrimidine, Oxadiazole, and Azo Moieties Endowed with Pharmaceutical Potency.

34. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.

35. Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii.

36. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.

37. Impaired social behaviour and molecular mediators of associated neural circuits during chronic Toxoplasma gondii infection in female mice.

38. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.

39. Non-Propellant Foams of Green Nano-Silver and Sulfadiazine: Development and In Vivo Evaluation for Burn Wounds.

40. Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro via Structure-Based Design.

41. Types of antiseptics, presentations and rules of use.

42. Influence of sulfadiazine on anaerobic fermentation of waste activated sludge for volatile fatty acids production: Focusing on microbial responses.

43. Response of microorganisms in biofilm to sulfadiazine and ciprofloxacin in drinking water distribution systems.

44. Effect of sulfadiazine and trimethoprim on activated sludge performance and microbial community dynamics in laboratory-scale membrane bioreactors and sequencing batch reactors at 8°C.

45. A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii.

46. Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition.

47. Probabilistic risk model to assess the potential for resistance selection following the use of anti-microbial medicated feed in pigs.

48. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.

49. Extended spectrum of antibiotic susceptibility for tuberculosis, Djibouti.

50. Effect of residual doxycycline concentrations on resistance selection and transfer in porcine commensal Escherichia coli.

Catalog

Books, media, physical & digital resources